SAVA Q4 2016 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,335

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$845,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$665,000

Stockholders' Equity

$19M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,335	-$3,620	+63.1%
Operating Income	-$3M	-$5M	+43.9%
Net Income	-$3M	-$5M	+44.2%